Filing Flows › Bio-Techne (TECH) › How it makes money
How Bio-Techne (TECH) makes money
Bio-Techne (TECH) made $300M of revenue in the first quarter fiscal 2027 (Q1 FY27), +5% from a year earlier. Product and Services brought in $285M (95%); Royalty brought in $14.5M (5%). Of every dollar of revenue, 66¢ was left as gross profit, 12¢ was left as operating profit, 9¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q1 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Product and Services | $285M | 95.2% | -10% | +2% |
| ↳ Consumables | $237M | 79.2% | -9% | +2% |
| ↳ Instruments | $25.5M | 8.5% | -19% | +17% |
| ↳ Services | $22.5M | 7.5% | -3% | -18% |
| Royalty | $14.5M | 4.8% | +147% | +157% |
Where each dollar of revenue goes
| Line | Q1 FY27 | % of revenue |
|---|---|---|
| Revenue | $300M | 100.0% |
| Cost of revenue | $103M | 34.4% |
| Gross profit | $197M | 65.6% |
| Operating expenses | $160M | 53.4% |
| Operating profit | $36.6M | 12.2% |
| Income tax | $6.4M | 2.1% |
| Net earnings | $28.3M | 9.4% |
| Operating cash flow | $73.1M | 24.4% |
| Free cash flow | $67.2M | 22.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q1 FY27 | $300M | +5% |
| Q4 FY26 | $321M | +1% |
| Q3 FY26 | $311M | -2% |
| Q2 FY26 | $296M | -0.4% |
| Q1 FY26 | $287M | -1% |
| Q4 FY25 | $317M | +4% |
| Q3 FY25 | $316M | +4% |
From Bio-Techne's 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does Bio-Techne make money?
Bio-Techne (TECH) made $300M of revenue in the first quarter fiscal 2027 (Q1 FY27), +5% from a year earlier. Product and Services brought in $285M (95%); Royalty brought in $14.5M (5%). Of every dollar of revenue, 66¢ was left as gross profit, 12¢ was left as operating profit, 9¢ was left as net earnings.
What is Bio-Techne's biggest business?
Product and Services: $285M in the first quarter fiscal 2027, 95% of revenue, +2% from a year earlier.
What is Bio-Techne's profit margin?
Net earnings were $28.3M, 9.4% of revenue, in the first quarter fiscal 2027; the operating margin was 12.2%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.